Effect of Alemtuzumab on Microglial Activation Positron Emission Tomography (PET) in Multiple Sclerosis

NCT03983252 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study was terminated without recruitment.

Conditions

Multiple Sclerosis

Interventions

DRUG: [F-18]PBR06

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]